Guaranteed on-time patient recruitment in Central and Eastern Europe

In 90% of studies organized by OCT patients enrollment goals have been met ahead-of or on-time. Due to OCT significant clinical sites and investigators database, we are able to recruit patients on-time even in exclusive orphan drug studies. OCT feasibility team contributes to our success by individual examination of each site’s enrollment potential. The total population OCT has access to is approximately 200 million people in 7 countries. Russia, Ukraine, Belarus, Latvia, Lithuania and Estonia are a considerable market. Patients can be found easily, as the healthcare system remains highly centralized in these countries. Hence, recruiting patients into clinical trials is much easier than in other countries.

Back to list